HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaotian Yuan Selected Research

Hepatocellular Carcinoma (Hepatoma)

10/2018Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
4/2017The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaotian Yuan Research Topics

Disease

19Neoplasms (Cancer)
11/2022 - 12/2014
6Carcinogenesis
05/2022 - 07/2016
4Thyroid Neoplasms (Thyroid Cancer)
11/2022 - 01/2019
4Neoplasm Metastasis (Metastasis)
05/2022 - 12/2014
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 12/2014
2Diarrhea
01/2023 - 12/2022
2Carcinoma (Carcinomatosis)
01/2021 - 12/2014
2Hepatocellular Carcinoma (Hepatoma)
10/2018 - 04/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023
1Breast Neoplasms (Breast Cancer)
01/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Escherichia coli Infections
12/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022
1Renal Cell Carcinoma (Grawitz Tumor)
05/2022
1Nasopharyngeal Carcinoma
01/2022
1Inflammation (Inflammations)
01/2022
1Experimental Arthritis
01/2022
1Adenocarcinoma of Lung
10/2021
1Prostatic Neoplasms (Prostate Cancer)
10/2021
1Chromosomal Instability (Chromosome Stability)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Leukemia
01/2020
1Acute Erythroblastic Leukemia (Erythroleukemia)
01/2020
1Primary Myelofibrosis (Myelosclerosis)
01/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2017
1Fibrosis (Cirrhosis)
03/2017
1Chronic Hepatitis B
03/2017
1Contact Dermatitis (Eczema, Contact)
01/2017

Drug/Important Bio-Agent (IBA)

16Telomerase (Telomerase Reverse Transcriptase)IBA
11/2022 - 05/2016
4Biomarkers (Surrogate Marker)IBA
12/2022 - 12/2014
4Transcription Factors (Transcription Factor)IBA
03/2022 - 01/2019
2Epidermal Growth Factor (EGF)IBA
05/2023 - 01/2023
2pyrotinibIBA
01/2023 - 12/2022
2EnzymesIBA
07/2017 - 01/2017
1Tyrosine Kinase InhibitorsIBA
01/2023
1Cyclic AMP (AMP, Cyclic)IBA
01/2023
1Bile Acids and Salts (Bile Acids)IBA
01/2023
1Glycocholic AcidIBA
01/2023
1Kynurenic Acid (Kynurenate)IBA
01/2023
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2023
1ErbB Receptors (EGF Receptor)IBA
01/2023
1Therapeutic UsesIBA
12/2022
1PowdersIBA
12/2022
1Interleukin-17 (Interleukin 17)IBA
12/2022
125-hydroxycholesterolIBA
12/2022
1guanidinosuccinic acidIBA
12/2022
1BaizhuIBA
12/2022
1Proto-Oncogene Proteins c-etsIBA
05/2022
1Transforming Growth Factor-beta Type II ReceptorIBA
05/2022
1Interleukin-2 (IL2)IBA
01/2022
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1lyonisideIBA
01/2022
1Hormones (Hormone)IBA
10/2021
1tacrolimus binding protein 4 (FKBP52)IBA
10/2021
1Nanoparticle Drug Delivery SystemIBA
11/2020
1Ursolic AcidIBA
11/2020
1Phenobarbital (Luminal)FDA Link
01/2020
1ruxolitinibIBA
01/2020
1NucleoproteinsIBA
01/2020
1LY2784544IBA
01/2020
1ElementsIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1MethyltransferasesIBA
10/2018
1Histone ChaperonesIBA
07/2017
1ChromatinIBA
07/2017
1Histones (Histone)IBA
07/2017
1CateninsIBA
07/2017
1Messenger RNA (mRNA)IBA
03/2015
1Tumor Biomarkers (Tumor Markers)IBA
12/2014

Therapy/Procedure

5Therapeutics
05/2022 - 01/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2022
1Immunotherapy
01/2022
1Precision Medicine
05/2016